Bolt Biotherapeutics (BOLT)
(Delayed Data from NSDQ)
$0.73 USD
0.00 (0.00%)
Updated Jul 24, 2024 03:46 PM ET
After-Market: $0.74 +0.01 (1.36%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-0.54 | 0.00% |
Earnings Summary
For their last quarter, Bolt Biotherapeutics (BOLT) reported earnings of -$0.28 per share, beating the Zacks Consensus Estimate of $-0.51 per share. This reflects a positive earnings surprise of 45.10%. Look out for BOLT's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$0.54 per share, reflecting a year-over-year decrease of 12.5%.
Earnings History
Price & Consensus
Zacks News for BOLT
UniQure (QURE) Reports Q3 Loss, Lags Revenue Estimates
BOLT: What are Zacks experts saying now?
Zacks Private Portfolio Services